نتایج جستجو برای: guérin bcg

تعداد نتایج: 9027  

2011
Nunzia Sanarico Alessia Colone Manuela Grassi Viviana Speranza Daniela Giovannini Antonio Ciaramella Vittorio Colizzi Francesca Mariani

In order to analyze dendritic cells (DCs) activation following infection with different mycobacterial strains, we studied the expression profiles of 165 genes of human monocyte-derived DCs infected with H37Rv, a virulent Mycobacterium tuberculosis (MTB) laboratory strain, CMT97, a clinical MTB isolate, Mycobacterium bovis bacillus Calmette-Guérin (BCG), Aventis Pasteur, and BCG Japan, both empl...

Journal: :Proceedings. Biological sciences 2011
Mark A Chambers Fiona Rogers Richard J Delahay Sandrine Lesellier Roland Ashford Deanna Dalley Sonya Gowtage Dipesh Davé Si Palmer Jacky Brewer Timothy Crawshaw Richard Clifton-Hadley Steve Carter Chris Cheeseman Chris Hanks Alistair Murray Kate Palphramand Stéphane Pietravalle Graham C Smith Alexandra Tomlinson Neil J Walker Gavin J Wilson Leigh A L Corner Stephen P Rushton Mark D F Shirley George Gettinby Robbie A McDonald R Glyn Hewinson

Control of bovine tuberculosis (TB) in cattle has proven particularly challenging where reservoirs of infection exist in wildlife populations. In Britain and Ireland, control is hampered by a reservoir of infection in Eurasian badgers (Meles meles). Badger culling has positive and negative effects on bovine TB in cattle and is difficult, costly and controversial. Here we show that Bacillus Calm...

Journal: :The Journal of infectious diseases 2003
Kaeryn N Lewis Reiling Liao Kristi M Guinn Mark J Hickey Sherilyn Smith Marcel A Behr David R Sherman

The tuberculosis (TB) vaccine bacille Calmette-Guérin (BCG) is a live attenuated organism, but the mutation responsible for its attenuation has never been defined. Recent genetic studies identified a single DNA region of difference, RD1, which is absent in all BCG strains and present in all Mycobacterium tuberculosis (MTB) strains. The 9 open-reading frames predicted within this 9.5-kb region a...

Journal: :Cancer research 1992
E C Lattime L G Gomella P A McCue

Intravesical administration of Bacillus Calmette-Guérin (BCG) is the most effective therapy for superficial transitional cell carcinoma of the bladder although its mechanism of action is not known. To determine if bladder tumors are capable of antigen presentation and thus might interact directly with BCG-specific T-cells, we studied the murine bladder tumor MB49. MB49 (MHC Class II negative) (...

2011
Alice Zwerling Marcel A. Behr Aman Verma Timothy F. Brewer Dick Menzies Madhukar Pai

Tuberculosis (TB) remains one of the major causes of infectious morbidity and mortality globally, claiming millions of lives every year. Approximately one-third of the world’s population is estimated to be infected with Mycobacterium tuberculosis, giving rise to 9.4 million new cases of active TB disease each year [1]. The majority of the TB burden exists in 22 high-burden countries, but with i...

Journal: :The Journal of Experimental Medicine 1951
W. Emanuel Suter René J. Dubos

Three different cultures of BCG propagated for over 2 years in a liquid medium containing Tween 80 and albumin were found to differ in several of their intrinsic properties. Cultures of the three strains were found to consist of morphologically heterogeneous populations-each culture being made up of three main colonial types-spreading, intermediate, and non-spreading. The percentage distributio...

2016
Nihar Ranjan Dash

In TB, prophylactic immunization plays a key preventive strategy. A live attenuated vaccine called bacille CalmetteGuérin (BCG) was developed way back in 1906 by Albert Calmette and Camille Guérin. The BCG vaccine was derived from an attenuated strain of Mycobacterium bovis and first used on humans in 1921 in France [2]. Currently the vaccine is given to neonates and children as a part of unive...

2015
Periela da Silva Sousa-Vasconcelos Wellington da Silva Seguins Eduardo de Souza Luz Rosa Teixeira de Pinho

Tuberculosis has great public health impact with high rates of mortality and the only prophylactic measure for it is the Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine. The present study evaluated the release of cytokines [interleukin (IL)-1, tumour necrosis factor and IL-6] and chemokines [macrophage inflammatory protein (MIP)-1α and MIP-1β] by THP-1 derived macrophages infected wi...

Journal: :The Journal of infectious diseases 2004
Rachel Pinto Bernadette M Saunders Luis R Camacho Warwick J Britton Brigitte Gicquel James A Triccas

We demonstrate that Mycobacterium tuberculosis that is unable to export the complex lipid phthiocerol dimycocerosate has a decreased capacity to replicate in mice and affords sustained protective immunity against M. tuberculosis infection Protection was significantly better than that provided by the existing vaccine, Mycobacterium bovis bacille Calmette-Guérin (BCG), and this improved protectiv...

Journal: :Memorias do Instituto Oswaldo Cruz 2005
Thereza Christina Benévolo-de-Andrade Renata Monteiro-Maia Catherine Cosgrove Luiz Roberto R Castello-Branco

The vaccine Bacillus of Calmette Guérin (BCG) was originally developed in France as an oral vaccine against tuberculosis. The oral use of this vaccine was replaced by the parenteral route in almost all countries after the Lubeck disaster. In contrast, Brazil retained the oral delivery of the vaccine until the mid-seventies when it was replaced by the intradermal route. This change in route of d...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید